RMRobert Mills-Goodlet

Robert Mills-Goodlet

*This is an algorithmically generated author record based on publicly available information.

Robert Mills-Goodlet has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Validation of the Epi2SensA Method Using the EpiDerm™ Model for Skin Sensitization Testing Under OECD TG442D

    by Christian Pellevoisin, Hajime Kojima, Sebastian Hoffmann, Takao Ashikaga, Timothy Landry, Celina Romero, Kalyani Guntur, Mitchell Klausner, Jennifer Stadnicki, Helge Gehrke, et al.

    The Epi2SensA method is a method similar to the validated EpiSensA assay for assessing the skin sensitization potential of chemicals. The Epi2SensA protocol includes adaptation (changes to exposure conditions and the controls) for using an alternative reconstructed human epidermis (RhE) model, the EpiDerm™ model. The interlaboratory validation study evaluated the reliability and predictive capacity of Epi2SensA according to OECD Performance Standards. Four laboratories (Mattek, Now Part of Sartorius, Eurofins Munich, Burleson Research Technologies, Inc., and Food and Drug Safety Center) conducted blinded testing of 20 coded reference substances representing various chemical categories and sensitization potencies. Statistical analysis using modified acceptance criteria (a 60% cell viability threshold) and a modified prediction model (requiring at least two positive gene markers) demonstrated substantially improved performance compared to the original EpiSensA criteria. The between-laboratory reproducibility (BLR) was 85%, the average within-laboratory reproducibility (WLR) was 83.3%, and the average predictivity parameters were 88.1% for sensitivity, 88.9% for specificity, and 88.3% for accuracy. Epi2SensA achieved performance metrics comparable to the validated reference method (EpiSensA), supporting regulatory acceptance of the Epi2SensA assay using the EpiDerm™ model (Mattek Corporation, Now Part of Sartorius, Ashland, MA, USA) as an alternative RhE source for OECD TG 442D skin sensitization testing.

  • Open Access

    The nanotopography of SiO2particles impacts the selectivity and 3D fold of bound allergens

    by Robert Mills-Goodlet, Litty Johnson, Isabel J. Hoppe, Christof Regl, Mark Geppert, Milena Schenck, Sara Huber, Michael Hauser, Fátima Ferreira, Nicola Hüsing, et al.

    A detailed description of the changes that occur during the formation of protein corona represents a fundamental question in nanoscience, given that it not only impacts the behaviour of nanoparticles but also affects the bound proteins. Relevant questions include whether proteins selectively bind particles, whether a specific orientation is preferred for binding, and whether particle binding leads to a modulation of their 3D fold. For allergens, it is important to answer these questions given that all these effects can modify the allergenic response of atopic individuals. These potential impacts on the bound allergen are closely related to the specific properties of the involved nanoparticles. One important property influencing the formation of protein corona is the nanotopography of the particles. Herein, we studied the effect of nanoparticle porosity on allergen binding using mesoporous and non-porous SiO2 NPs. We investigated (i) the selectivity of allergen binding from a mixture such as crude pollen extract, (ii) whether allergen binding results in a preferred orientation, (iii) the influence of binding on the conformation of the allergen, and (iv) how the binding affects the allergenic response. Nanotopography was found to play a major role in the formation of protein corona, impacting the physicochemical and biological properties of the NP-bound allergen. The porosity of the surface of the SiO2 nanoparticles resulted in a higher binding capacity with pronounced selectivity for (preferentially) binding the major birch pollen allergen Bet v 1. Furthermore, the binding of Bet v 1 to the mesoporous rather than the non-porous SiO2 nanoparticles influenced the 3D fold of the protein, resulting in at least partial unfolding. Consequently, this conformational change influenced the allergenic response, as observed by mediator release assays employing the sera of patients and immune effector cells. For an in-depth understanding of the bio-nano interactions, the properties of the particles need to be considered not only regarding the identity and morphology of the material, but also their nanotopography, given that porosity may greatly influence the structure, and hence the biological behaviour of the bound proteins. Thus, thorough structural investigations upon the formation of protein corona are important when considering immunological outcomes, as particle binding can influence the allergenic response elicited by the bound allergen.


  • Open Access

    Biological effects of allergen–nanoparticle conjugates: uptake and immune effects determined on hAELVi cells under submerged vs. air–liquid interface conditions

    by Robert Mills-Goodlet, Milena Schenck, Aline Chary, Mark Geppert, Tommaso Serchi, Sabine Hofer, Nobert Hofstätter, Andrea Feinle, Nicola Hüsing, Arno C. Gutleb, et al.

    Type I hypersensitivity reactions against environmental entities, i.e. allergens, are an ever growing problem, with increasing numbers of affected individuals in Western countries. In parallel, nanotechnology has been growing during the past decades, entering more and more areas of application in everyday life. Exposure to allergens may occur in a combined way with environmental particulate matter or (nano-)particles potentially abundant at the workplace. Such combinations may thus affect workers and consumers alike. The present study conceived a methodological and mechanistic approach based on recombinant allergen–SiO2 nanoparticle conjugates and the novel hAELVi cell line as two well-defined model systems to investigate the effects of co-exposure towards allergens and nanoparticles. We applied pristine nanoparticles, allergen–nanoparticle conjugates and unbound allergen under submerged and air–liquid interface conditions. The uptake kinetics and mechanisms, cellular localization and resulting immune responses were studied in hAELVi cells, a cell line derived from human alveolar epithelium showing the characteristics of type I epithelial cells. Modification in the uptake kinetics as well as an increase in pro-inflammatory cyto-/chemokine expression was observed under submerged conditions, but much less under air–liquid interface conditions. While for mechanistic investigations the submerged culture system still proved suitable, more robust and cost-effective, these culture conditions showed considerable deviations in cellular susceptibility observed under more realistic conditions.


  • Biologic effects of nanoparticle-allergen conjugates: time-resolved uptake using an in vitro lung epithelial co-culture model of A549 and THP-1 cells

    by Bettina Grotz, Mark Geppert, Robert Mills-Goodlet, Sabine Hofer, Norbert Hofstätter, Claudia Asam, Andrea Feinle, Krisztina Kocsis, Thomas Berger, Oliver Diwald, et al.

    Nanotechnology is a fast growing field and already a multi-billion dollar market with numerous products available for consumers. TiO2 and SiO2 are by mass the most produced nanomaterials and, thus, of particular interest regarding their biological effects upon inhalation – especially in combination with other inhalable biomolecules such as allergens. We investigated the protein-binding capacity of these two nanomaterials and present detailed uptake profiles of protein-conjugated TiO2 or SiO2 nanoparticles (NPs) in A549 lung epithelial and THP-1 macrophage-like cells. TiO2 and SiO2 NPs (both with a hydrodynamic diameter of about 150 nm) are able to bind bovine serum albumin (BSA), green fluorescent protein (GFP) and the major birch pollen allergen Bet v 1 in substantial amounts that suggest protein monolayers around the particles. GFP-conjugated TiO2 and SiO2 NPs were taken up in A549 and THP-1 cells in a time-dependent manner as demonstrated by confocal laser scanning microscopy, flow cytometry and life cell imaging. By the aid of fluorescent proteins (GFP or fluorescently labeled Bet v 1) we found that both, the NPs and the conjugated proteins entered the cells. Using A549/THP-1 co-cultures, we showed that the majority of SiO2 NPs is taken up by THP-1 cells; however, also A549 cells take up significant amounts of particles when co-cultured with THP-1 macrophage-like cells. The here discussed data provide valuable insights into protein (allergen) delivery by NPs at the lung epithelial barrier.


  • Open Access

    Nanomaterials in the Context of Type 2 Immune Responses—Fears and Potentials

    by Martin Himly, Robert Mills-Goodlet, Mark Geppert, Albert Duschl

    Preface The type 2 immune response is an adaptive immune program involved in defense against parasites, detoxification and wound healing, but is predominantly known for its pathophysiological effects, manifesting as allergic disease. Engineered nanoparticles are non-self entities that, to our knowledge, do not stimulate detrimental type 2 responses directly, but have the potential to modulate ongoing reactions in various ways, including the delivery of substances aiming at providing a therapeutic benefit. We review here the state of knowledge concerning the interaction of nanoparticles with type 2 immune responses and highlight their potential as a multifunctional platform for therapeutic intervention.